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The complete amino acid sequences of human kidney cathepsin H (EC 3.4.22.16) and human kidney cathepsin L (EC 
3.4.22.15) were determined. Cathepsin H contains 230 residues and has an M, of 25 116. The sequence was obtained by 
sequencing the light, heavy and mini chain and the peptides produced by cyanogen bromide cleavage of the single-chain 
form of the enzyme. The glycosylated mini chain is a proteolytic fragment of the propeptide of cathepsin H. Human 
cathepsin L has 217 amino acid residues and an IV, of 23720. Its amino acid sequence was deduced from N-terminal 
sequences of the heavy and light chains and from the sequences of cyanogen bromide fragments of the heavy chain. The 
fragments were aligned by comparison with known sequences of cathepsins H and L from other species. Cathepsins H 
and L exhibit a high degree of sequence homology to cathepsin B (EC 3.4.22.1) and other cysteine proteinases of the 
papain superfamily. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Tissue cysteine proteinases cathepsins B, H, L 
and S are generally thought to play an important 
role in intracellular protein degradation. Their 
properties and the first available structural data 
suggested that these enzymes belong to the papain 
superfamily [ 11. The amino acid sequences of dif- 
ferent animal cysteine proteinases such as rat 
cathepsin B [2,3], rat cathepsin H [2], bovine 
cathepsin B [4], mouse cysteine proteinase [5], 
chicken cathepsin L [6,7] and rat cathepsin L [8] 
support this classification. In addition amino acid 
sequences of human cathepsin B obtained at both 
the protein [9] and nucleic acid level [lo, 1 l] show 
high sequence homology. to the cysteine pro- 
teinases mentioned above, confirming that further 
evolutionary divergence has occurred within this 
superfamily. 
Active human kidney cathepsin H was purified as in [12]. 
Cathepsin L was isolated from human kidney as described in 
1131. 
All chemicals used were of analytical grade. Iodo[3H]acetic 
acid was from Amersham. Standards used for the molecular 
mass determinations were from Serva. 
Apparent molecular masses of cathepsins H and L and their 
pre-existing proteolytic fragments were determined by gel 
chromatography on a calibrated Sephacryl S-200 column eluted 
with 80% formic acid as described [16]. 
For reduction and alkylation, the samples were dissolved in 
0.5 M Tris, pH 8.0, containing 5 mM EDTA and 6 M 
guanidine hydrochloride, reduced with 10 mM 2-mercapto- 
ethanol and then alkylated with 10 mM iodo[‘H]acetic acid. 
For the determination of free SH groups, native and active 
cathepsin H or L were alkylated with iodo[‘H]acetic acid 
without prior reduction. 
Here we report for the first time the complete 
amino acid sequences of enzymatically active 
cathepsins H and L of human origin. 
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Amino acid analyses were performed with a Kontron 
Liquimat II analyser using fluorescence detection after a post- 
column reaction with o-phthalaldehyde. The samples were 
hydrolyzed with 5.7 N HCl in evacuated sealed tubes for 24 and 
72 h. Peptides were hydrolyzed for only 24 h. For CNBr 
cleavage, the alkylated samples were dissolved in 70% formic 
acid and incubated with a lOO-fold molar excess of CNBr over 
methionyl residues for 48 h in the dark at room temperature. 
The resulting peptides were separated by gel chromatography 
on a Sephacryl S-200 column (0.6 X 150 cm) in 80% formic acid 
and by the reverse-phase HPLC on a Gynkotek RP Cl8 column 
using gradients of acetonitrile in 0.1 Vo trifluoroacetic acid. 
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Amino acid sequences were determined by automated solid- 
phase Edman degradation using a non-commercial sequencer. 
The amino acid phenylthiohydantoin derivatives were identified 
and quantified by the reverse-phase HPLC operating on-line to 
the sequencer [14]. Prior to sequencing the peptides were 
covalently coupled to porous glass supports as described [15]. 
Cysteine was identified as S-[-‘H]carboxymethylcysteine 
phenylthiohydantoin by liquid-scintillation counting. 
3. RESULTS AND DISCUSSION 
3.1. Amino acid sequence of cathepsin H
Active cathepsin H eluting as a single sym- 
metrical peak on a Sephacryl S-200 column (Mr 
about 27000) contained four different N-terminal 
sequences. When chromatographed on the same 
column after reduction and S-carboxymethylation, 
the sample separated into three peaks [16]. The 
molecular mass of the first peak remained 27 kDa 
and yielded two N-terminal sequences in a ratio at 
3 : 2. The higher amount represents the polypeptide 
chain starting with Tyr and the lower portion cor- 
responds to a chain with two more residues, Gly 
and Pro, at the N-terminal (fig.1). Probably these 
two residues have been cleaved off by the 
aminopeptidase activity of cathepsin H giving rise 
to the shorter form. Further degradation of the en- 
zyme was stopped by two successive proline 
residues at the second and third position. The se- 
cond chromatographic peak was a 42 residues long 
peptide amounting to approx. 20% of the total en- 
zyme as determined from the yields of the N- 
terminal sequences. This peptide represents the 
light chain corresponding to the C-terminal part of 
the enzyme (fig. 1). 8OYo of the enzyme was present 
as the single chain. The difference in molecular 
mass due to the light chain was too small to 
separate the single-chain form from the heavy 
chain by gel chromatography. The third peak was 
a glycosylated octapeptide containing one cysteine 
residue which was disulfide linked to the rest of the 
native cathepsin H molecule, as we reported earlier 
[16]. Using DNA sequence data, this octapeptide, 
named mini chain, has been found to be part of the 
propeptide region of the enzyme (Chan, S.J. et al., 
personal communication). All preparations of the 
active enzyme tested by N-terminal sequencing 
contained equimolar amounts of the mini chain 
and the rest of the enzyme. 
The sample from the 27 kDa peak was used for 
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Fig.1. Amino acid sequence and composition of human 
cathepsin H and strategy of sequence determination. The 
sequence of the human cathepsin H protein was obtained by N- 
terminal degradation of the whole enzyme (NT), its light chain 
(LC), a complete set of cyanogen bromide fragments 
(CB-l-CB-7) of the S-[‘Hlcarboxymethylated protein and of 
the mini chain (MC) which was separated from the rest of the 
enzyme after reduction and S-carboxymethylation. Numbering 
of the protein sequence refers to the major component, a minor 
form was found to be N-terminally extended by two residues 
(CB-IA). Bars indicate the fragments used for sequence 
determination; (0) residues that have been directly identified 
by solid-phase Edman degradation of the individual fragments, 
(x) residues that have not been identified. Cysteine was 
detected by radioactivity of its S-[‘H)carboxymethyl derivative. 
Glycosylated asparaginyl residues were tentatively assigned to 
position 115 and position 4” of the mini chain (underlined) 
where unknown polar PTH-derivatives were found to yield 
aspartic acid after hydrolysis. 
chemical cleavage at methionyl bonds. The 
cyanogen bromide peptides (CB-l-CB-7) were se- 
quenced. The strategy for amino acid sequence 
analysis is outlined in fig.1. N-terminal degrada- 
tion of the active enzyme resulted in 46 residues 
which were confirmed by the sequence of the CB-I 
peptide. The sequence of the CB-2 peptide com- 
prises the residues 49-87 and that of CB-3 the 
residues 88-126. Residue 117 is presumably 
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glycosylated. The peptide CB-5 overlaps the C- 
terminal part of the heavy chain and the N- 
terminal part of the light chain in the single-chain 
form enzyme. CB-7 is the C-terminal part of the 
enzyme molecule identified by the lack of C- 
terminal homoserine. Its sequence is identical to 
the C-terminal sequence of the light chain. 
The non-overlapped fragments were aligned by 
their homology to the corresponding parts of the 
known sequence of cathepsin H from the rat [2]. 
The obtained sequence of the human cathepsin H 
protein was found to be identical with the amino 
acid sequence predicted from the cDNA sequence 
of human preprocathepsin H (Chan, S.J. et al., 
personal communication), with the exception that 
we found a glutamic acid residue in position 191 
instead of glutamine. 
Active cathepsin H is composed of 230 amino 
acid residues, 222 of which form a single chain and 
an 8 residue long mini chain which is disulfide- 
linked to the rest of the enzyme. The minor portion 
of the two chain form results from proteolytic 
cleavage of a single peptide bond between Asp-177 
and Gly-178. In contrast to human cathepsin B 
[I I] and L (see below) the mature cathepsin H has 
the same C-terminal sequence as its precursor. 
3.2. Amino acid sequence of cathepsin L 
Active cathepsin L with a molecular mass of 
about 22 kDa yielded two N-terminal sequences in 
a 1: 1 molar ratio, as we have reported [16]. After 
reduction and S-carboxymethylation, the sample 
separated into a 17 kDa heavy chain and 5 kDa 
light chain on a Sephacryl S-200 column. The 
heavy chain was cleaved at methionyl residues. 
Five peptides (CB-I-CB-5) were obtained, 
purified and sequenced (fig.2). The sequence of the 
N-terminal peptide CB-1 was known from the N- 
terminal sequence of the heavy chain. The peptide 
CB-5 is the C-terminal peptide of the heavy chain 
because its C-terminal residue is Thr and not the 
methionyl derivative homoserine. 
Alignment of the peptides CB-2, CB-3 and CB-4 
was done by comparison with the cDNA-derived 
amino acid sequences of mouse cysteine proteinase 
[5] and of rat preprocathepsin L [8]. The resulting 
sequence of the human cathepsin L protein (fig.2) 
was found to be consonant with the cDNA-derived 
amino acid sequence of human preprocathepsin L
(Gal, S. et al., personal communication) except for 
Fig.2. Amino acid sequence and composition of human 
cathepsin L and strategy of sequence determination. The amino 
acid sequence of S-[3H]carboxymethylated human cathepsin L 
was determined by the automated solid-phase Edman 
degradation of the heavy chain (HC), the light chain (LC) and 
of five cyanogen bromide fragments of the heavy chain 
(CB-I-CB-5). The fragments used for sequence analysis are 
indicated by bars; (0) residues that were directly identified by 
Edman degradation of the individual fragments, (x) residues 
which were not directly identified. Cysteine was determined by 
radioactivity of its S-[‘Hlcarboxymethyl derivative. Two 
glycosylation sites of the type N-X-T/S are tentatively assumed 
at positions 108 and 155 (underlined) where no residue and a 
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low amount of asparagine were found, respectively. 
residues 176-178 which are missing at the C- 
terminus of the heavy chain. From these results we 
conclude that mature human cathepsin L is com- 
posed of 217 amino acid residues forming a heavy 
chain of 175 residues and a light chain of 42 
residues. 
In both active cathepsins H and L we have found 
one free SH-group. We expect that active cathep- 
sin H from the total content of cysteine residues 
(figs 1,2) contains 4 disulfide bridges, whereas 
three are present in the active cathepsin’ L 
molecule. In human cathepsin B we have found 
343 
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Fig.3. Sequences of the three human cathepsins H, L and B are 
compared with that of the plant proteinase papain. The 
sequences were aligned to achieve maximal homology. Residues 
identical in all four proteinases are boxed. Numbering of 
residues refers to cathepsin B. 
one free SH-group and 13 half cystines [9]. 
Cathepsin B probably forms 7 disulfide bridges; 
the missing half cystine should be positioned in the 
propeptide region. It seems that the ‘mini chain’ of 
cathepsin B containing this cysteine residue was 
lost after reduction of the starting samples. 
3.3. Sequence homology 
The sequences of human cathepsins H and L are 
compared with those of human cathepsin B and of 
papain in fig.3. For comparison the sequences are 
arbitrarily divided into three regions [2] as shown 
in table 1. In the active site cysteinyl region the 
three human cathepsins how 31-56% of identity, 
the highest (56%) being between cathepsins L and 
H and the lowest (31%) when cathepsin H is com- 
pared to cathepsin B. 24% of the residues are iden- 
tical in all four proteinases. These structural 
similarities of cathepsins and papain are probably 
due to divergence from a common ancestral gene 
344 
Table 1 
Homology of amino acid sequences of human cathepsins B, H 
and L and papain 
Residues in CB 
l-252 l-77 78-152 153-252 
(whole (active site (central (active site 
protein) cysteinyl region) histidyl 
region) region) 
CH/CB 30.0 31.1 15.5 35.6 
CL/CB 29.9 34.2 19.5 31.6 
CL/CH 45.1 56.1 30.4 43.8 
Ident. resid.a 13.8 24.3 9.3 11.1 
a Identical residues in all four enzymes as indicated in fig.3 
Identity in (o/o) was calculated from the sequence alignment 
shown in fig.3. (CH) cathepsin H, (CB) cathepsin B, (CL) 
cathepsin L 
during evolution. The degree of identity in the cen- 
tral region is low (9.3%) in spite of a rather liberal 
placement of the gaps. The functional significance 
of the central region is not clear even in papain, 
where the three-dimensional structure is estab- 
lished. In the C-terminal parts where the active site 
hystidyl regions are located, a lower degree of 
identity is observed compared to the cysteinyl 
regions (31-43070). Also, in this region cathepsin L 
is closely related to cathepsin H (43% identity) 
whereas it shows a lower homology with cathepsin 
B (3 1% identity). The sequences in the vicinity of 
the active site hystidinyl residue may reflect the dif- 
ferent peptidase specificities of the cathepsins as 
was suggested for cathepsin B [2]. Whereas cathep- 
sin L shows only endopeptidase activity [22], 
cathepsins B and H act as endopeptidases as well 
as dipeptidyl peptidase [17- 191 and aminopep- 
tidase [20,21], respectively. 
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